Shingles Vaccine Tied to Slower Aging
-
By
January 20, 2026
-
3 min
-
1
Shingles vaccination linked to slower epigenetic and transcriptomic aging.
-
2
Study involved 3,884 adults aged 70+.
-
3
Lower inflammation scores associated with vaccination.
-
4
Analysis used stabilized inverse probability of treatment weights.
-
5
Findings suggest vaccines can play a role in healthy aging strategies.
-
6
Limitations included self-reported vaccination status.
-
7
Results may not apply to newer recombinant shingles vaccines.
-
A recent study found that shingles vaccination in adults aged 70 years or older is associated with slower epigenetic and transcriptomic aging processes, as well as lowered inflammation scores, observed even beyond three years post-vaccination. The research analyzed data from 3,884 participants in the US Health and Retirement Study, assessing various biological aging domains related to the effects of vaccination. Findings suggest that vaccination may enhance healthy aging strategies, although limitations included potential recall errors and reliance on self-reported data.
-
1
Shingles vaccination linked to slower epigenetic and transcriptomic aging.
-
2
Study involved 3,884 adults aged 70+.
-
3
Lower inflammation scores associated with vaccination.
-
4
Analysis used stabilized inverse probability of treatment weights.
-
5
Findings suggest vaccines can play a role in healthy aging strategies.
-
6
Limitations included self-reported vaccination status.
-
7
Results may not apply to newer recombinant shingles vaccines.
Listen Tab content
